Skip to main content
Top
Published in: Current Osteoporosis Reports 6/2017

01-12-2017 | Craniofacial Skeleton (E Roberts, Section Editor)

Dental Manifestations of Pediatric Bone Disorders

Author: Juan F. Yepes

Published in: Current Osteoporosis Reports | Issue 6/2017

Login to get access

Abstract

Purpose of Review

Several bone disorders affecting the skeleton often are manifest in the maxillofacial region. This review presents the most common bone disorders in children and their dental–oral manifestations: fibrous dysplasia, Paget’s disease, osteogenesis imperfecta, renal osteodystrophy, hypophosphatasia, and osteoporosis. The specific intraoral characteristics will reviewed in detail.

Recent Findings

Recent studies confirmed the close relationship between the mandible and the maxilla with the most prevalent systemic bone disorders in children.

Summary

This review will help practitioners to integrate the oral health into the systemic health and improve the multidisciplinary approach of pediatric patients between medicine and dentistry.
Literature
2.
go back to reference Weinstein LS, et al. Activating mutations of the stimulatory G protein in the McCune-Albright syndrome. N Engl J Med. 1991;325(24):1688–95.CrossRefPubMed Weinstein LS, et al. Activating mutations of the stimulatory G protein in the McCune-Albright syndrome. N Engl J Med. 1991;325(24):1688–95.CrossRefPubMed
3.
go back to reference Riminucci M, et al. Osteoclastogenesis in fibrous dysplasia of bone: in situ and in vitro analysis of IL-6 expression. Bone. 2003;33(3):434–42.CrossRefPubMed Riminucci M, et al. Osteoclastogenesis in fibrous dysplasia of bone: in situ and in vitro analysis of IL-6 expression. Bone. 2003;33(3):434–42.CrossRefPubMed
4.
go back to reference Riminucci M, et al. The histopathology of fibrous dysplasia of bone in patients with activating mutations of the Gs alpha gene: site-specific patterns and recurrent histological hallmarks. J Pathol. 1999;187(2):249–58.CrossRefPubMed Riminucci M, et al. The histopathology of fibrous dysplasia of bone in patients with activating mutations of the Gs alpha gene: site-specific patterns and recurrent histological hallmarks. J Pathol. 1999;187(2):249–58.CrossRefPubMed
5.
go back to reference Hart ES, et al. Onset, progression, and plateau of skeletal lesions in fibrous dysplasia and the relationship to functional outcome. J Bone Miner Res. 2007;22(9):1468–74.CrossRefPubMed Hart ES, et al. Onset, progression, and plateau of skeletal lesions in fibrous dysplasia and the relationship to functional outcome. J Bone Miner Res. 2007;22(9):1468–74.CrossRefPubMed
8.
go back to reference Kelly MH, Brillante B, Collins MT. Pain in fibrous dysplasia of bone: age-related changes and the anatomical distribution of skeletal lesions. Osteoporos Int. 2008;19(1):57–63.CrossRefPubMed Kelly MH, Brillante B, Collins MT. Pain in fibrous dysplasia of bone: age-related changes and the anatomical distribution of skeletal lesions. Osteoporos Int. 2008;19(1):57–63.CrossRefPubMed
9.
go back to reference Lalam RK, Cassar-Pullicino VN, Winn N. Paget disease of bone. Semin Musculoskelet Radiol. 2016;20(3):287–99.CrossRefPubMed Lalam RK, Cassar-Pullicino VN, Winn N. Paget disease of bone. Semin Musculoskelet Radiol. 2016;20(3):287–99.CrossRefPubMed
10.
go back to reference Cundy HR, et al. Paget’s disease of bone in New Zealand: continued decline in disease severity. Calcif Tissue Int. 2004;75(5):358–64.CrossRefPubMed Cundy HR, et al. Paget’s disease of bone in New Zealand: continued decline in disease severity. Calcif Tissue Int. 2004;75(5):358–64.CrossRefPubMed
11.
go back to reference Tiegs RD, et al. Long-term trends in the incidence of Paget’s disease of bone. Bone. 2000;27(3):423–7.CrossRefPubMed Tiegs RD, et al. Long-term trends in the incidence of Paget’s disease of bone. Bone. 2000;27(3):423–7.CrossRefPubMed
12.
go back to reference Poor G, et al. Epidemiology of Paget’s disease in Europe: the prevalence is decreasing. J Bone Miner Res. 2006;21(10):1545–9.CrossRefPubMed Poor G, et al. Epidemiology of Paget’s disease in Europe: the prevalence is decreasing. J Bone Miner Res. 2006;21(10):1545–9.CrossRefPubMed
13.
go back to reference • Galson DL, Roodman GD. Pathobiology of Paget’s disease of bone. J Bone Metab. 2014;21(2):85–98. This study provides a detail description of the new and more recent knowledge about the physiopathology of Paget’s disease. CrossRefPubMedPubMedCentral • Galson DL, Roodman GD. Pathobiology of Paget’s disease of bone. J Bone Metab. 2014;21(2):85–98. This study provides a detail description of the new and more recent knowledge about the physiopathology of Paget’s disease. CrossRefPubMedPubMedCentral
14.
go back to reference Ralston SH, Layfield R. Pathogenesis of Paget disease of bone. Calcif Tissue Int. 2012;91(2):97–113.CrossRefPubMed Ralston SH, Layfield R. Pathogenesis of Paget disease of bone. Calcif Tissue Int. 2012;91(2):97–113.CrossRefPubMed
15.
go back to reference Roodman GD. Insights into the pathogenesis of Paget’s disease. Ann N Y Acad Sci. 2010;1192:176–80.CrossRefPubMed Roodman GD. Insights into the pathogenesis of Paget’s disease. Ann N Y Acad Sci. 2010;1192:176–80.CrossRefPubMed
16.
go back to reference Indumathi CK, Dinakar C, Roshan R. Juvenile Paget’s disease. Indian Pediatr. 2009;46(4):354–6.PubMed Indumathi CK, Dinakar C, Roshan R. Juvenile Paget’s disease. Indian Pediatr. 2009;46(4):354–6.PubMed
17.
go back to reference Wendlova J, Galbavy S, Paukovic J. Paget’s disease of bone—treatment with alendronate, calcium and calcitriol. Vnitr Lek. 1999;45(10):602–5.PubMed Wendlova J, Galbavy S, Paukovic J. Paget’s disease of bone—treatment with alendronate, calcium and calcitriol. Vnitr Lek. 1999;45(10):602–5.PubMed
18.
go back to reference Monti E, et al. Current and emerging treatments for the management of osteogenesis imperfecta. Ther Clin Risk Manag. 2010;6:367–81.PubMedPubMedCentral Monti E, et al. Current and emerging treatments for the management of osteogenesis imperfecta. Ther Clin Risk Manag. 2010;6:367–81.PubMedPubMedCentral
21.
go back to reference Hoyer-Kuhn H, et al. A specialized rehabilitation approach improves mobility in children with osteogenesis imperfecta. J Musculoskelet Neuronal Interact. 2014;14(4):445–53.PubMed Hoyer-Kuhn H, et al. A specialized rehabilitation approach improves mobility in children with osteogenesis imperfecta. J Musculoskelet Neuronal Interact. 2014;14(4):445–53.PubMed
22.
go back to reference Majorana A, et al. Dentinogenesis imperfecta in children with osteogenesis imperfecta: a clinical and ultrastructural study. Int J Paediatr Dent. 2010;20(2):112–8.CrossRefPubMed Majorana A, et al. Dentinogenesis imperfecta in children with osteogenesis imperfecta: a clinical and ultrastructural study. Int J Paediatr Dent. 2010;20(2):112–8.CrossRefPubMed
23.
go back to reference Kliegman R, Nelson WE. Nelson textbook of pediatrics. 19th ed. Philadelphia: Elsevier/Saunders. lxvii; 2011. p. 2610. Kliegman R, Nelson WE. Nelson textbook of pediatrics. 19th ed. Philadelphia: Elsevier/Saunders. lxvii; 2011. p. 2610.
24.
go back to reference Kalyvas D, et al. Localized jaw enlargement in renal osteodystrophy: report of a case and review of the literature. Oral Surg Oral Med Oral Pathol Oral Radiol Endod. 2004;97(1):68–74.CrossRefPubMed Kalyvas D, et al. Localized jaw enlargement in renal osteodystrophy: report of a case and review of the literature. Oral Surg Oral Med Oral Pathol Oral Radiol Endod. 2004;97(1):68–74.CrossRefPubMed
25.
go back to reference Lopes ML, et al. Severe maxillofacial renal osteodystrophy in two patients with chronic kidney disease. Oral Maxillofac Surg. 2015;19(3):321–7.CrossRefPubMed Lopes ML, et al. Severe maxillofacial renal osteodystrophy in two patients with chronic kidney disease. Oral Maxillofac Surg. 2015;19(3):321–7.CrossRefPubMed
26.
go back to reference Antonelli JR, Hottel TL. Oral manifestations of renal osteodystrophy: case report and review of the literature. Spec Care Dentist. 2003;23(1):28–34.CrossRefPubMed Antonelli JR, Hottel TL. Oral manifestations of renal osteodystrophy: case report and review of the literature. Spec Care Dentist. 2003;23(1):28–34.CrossRefPubMed
28.
go back to reference Anderson HC, et al. Matrix vesicles in osteomalacic hypophosphatasia bone contain apatite-like mineral crystals. Am J Pathol. 1997;151(6):1555–61.PubMedPubMedCentral Anderson HC, et al. Matrix vesicles in osteomalacic hypophosphatasia bone contain apatite-like mineral crystals. Am J Pathol. 1997;151(6):1555–61.PubMedPubMedCentral
29.
go back to reference Bloch-Zupan A. Hypophosphatasia: diagnosis and clinical signs—a dental surgeon perspective. Int J Paediatr Dent. 2016;26(6):426–38.CrossRefPubMed Bloch-Zupan A. Hypophosphatasia: diagnosis and clinical signs—a dental surgeon perspective. Int J Paediatr Dent. 2016;26(6):426–38.CrossRefPubMed
30.
go back to reference Schlosser BJ, Pirigyi M, Mirowski GW. Oral manifestations of hematologic and nutritional diseases. Otolaryngol Clin N Am. 2011;44(1):183–203. vii CrossRef Schlosser BJ, Pirigyi M, Mirowski GW. Oral manifestations of hematologic and nutritional diseases. Otolaryngol Clin N Am. 2011;44(1):183–203. vii CrossRef
33.
go back to reference Marrani E, et al. Pediatric osteoporosis: diagnosis and treatment considerations. Drugs. 2017;77(6):679–95.CrossRefPubMed Marrani E, et al. Pediatric osteoporosis: diagnosis and treatment considerations. Drugs. 2017;77(6):679–95.CrossRefPubMed
34.
go back to reference • Saraff V, Hogler W. Endocrinology and adolescence: osteoporosis in children: diagnosis and management. Eur J Endocrinol. 2015;173(6):R185–97. This article provides to the reader a detailed and completed review in the most updated knowledge of osteoporosis in children. CrossRefPubMed • Saraff V, Hogler W. Endocrinology and adolescence: osteoporosis in children: diagnosis and management. Eur J Endocrinol. 2015;173(6):R185–97. This article provides to the reader a detailed and completed review in the most updated knowledge of osteoporosis in children. CrossRefPubMed
35.
go back to reference Russell RG. Bisphosphonates: mode of action and pharmacology. Pediatrics. 2007;119(Suppl 2):S150–62.CrossRefPubMed Russell RG. Bisphosphonates: mode of action and pharmacology. Pediatrics. 2007;119(Suppl 2):S150–62.CrossRefPubMed
36.
go back to reference Dervis E. Oral implications of osteoporosis. Oral Surg Oral Med Oral Pathol Oral Radiol Endod. 2005;100(3):349–56.CrossRefPubMed Dervis E. Oral implications of osteoporosis. Oral Surg Oral Med Oral Pathol Oral Radiol Endod. 2005;100(3):349–56.CrossRefPubMed
Metadata
Title
Dental Manifestations of Pediatric Bone Disorders
Author
Juan F. Yepes
Publication date
01-12-2017
Publisher
Springer US
Published in
Current Osteoporosis Reports / Issue 6/2017
Print ISSN: 1544-1873
Electronic ISSN: 1544-2241
DOI
https://doi.org/10.1007/s11914-017-0409-5

Other articles of this Issue 6/2017

Current Osteoporosis Reports 6/2017 Go to the issue

Therapeutics and Medical Management (S Jan de Beur and B Clarke, Section Editors)

Vertebral Imaging in the Diagnosis of Osteoporosis: a Clinician’s Perspective

Osteocytes (T Bellido and J Klein-Nulend, Section Editors)

Diet and Exercise: a Match Made in Bone

Nutrition, Exercise and Lifestyle in Osteoporosis (S Shapses and J Lappe, Section Editors)

Exercise Frequency and Fracture Risk in Older Adults—How Often Is Enough?

Orthopedic Management of Fractures (S Bukata and L Gerstenfeld, Section Editors)

Effects of Aging on Fracture Healing